000			01548 a2200409 4500
005			20250513204056.0
264		0	_c20000512
008			200005s 0 0 eng d
022			_a1357-0560
024	7		_a10.1007/BF02826216 _2doi
040			_aNLM _beng _cNLM
100	1		_aLeaf, A N
245	0	0	_aPhase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385). _h[electronic resource]
260			_bMedical oncology (Northwood, London, England) _cFeb 2000
300			_a47-51 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Phytogenic _xtherapeutic use
650	0	4	_aDisease Progression
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIodine Radioisotopes _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aSample Size
650	0	4	_aThyroid Hormones _xtherapeutic use
650	0	4	_aThyroid Neoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
700	1		_aWolf, B C
700	1		_aKirkwood, J M
700	1		_aHaselow, R E
773	0		_tMedical oncology (Northwood, London, England) _gvol. 17 _gno. 1 _gp. 47-51
856	4	0	_uhttps://doi.org/10.1007/BF02826216 _zAvailable from publisher's website
999			_c10667611 _d10667611